Lineage Cell Therapeutics
LCTX
#8146
Rank
NZ$0.29 B
Marketcap
$1.51
Share price
-3.07%
Change (1 day)
-10.08%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2024 (TTM): -NZ$42.04 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are NZ$6.18 Million. In 2023 the company made an earning of -NZ$42.28 Million a decrease over its 2022 earnings that were of -NZ$38.49 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$42.04 Million-0.55%
2023 -NZ$42.28 Million9.83%
2022 -NZ$38.49 Million-54.24%
2021 -NZ$84.11 Million86.07%
2020 -NZ$45.21 Million-31.97%
2019 -NZ$66.45 Million-5.42%
2018 -NZ$70.25 Million1.1%
2017 -NZ$69.49 Million-31.06%
2016 -NZ$0.11 Billion-10.38%
2015 -NZ$0.12 Billion29.69%
2014 -NZ$86.72 Million31.68%
2013 -NZ$65.86 Million
2011 -NZ$31.96 Million89.78%
2010 -NZ$16.85 Million206.06%
2009 -NZ$5.51 Million-0.58%
2008 -NZ$5.54 Million164.89%
2007 -NZ$2.09 Million-30.22%
2006 -NZ$3 Million
2002 -NZ$3.48 Million-41.04%
2001 -NZ$5.9 Million-32.04%
2000 -NZ$8.68 Million-11.85%
1999 -NZ$9.85 Million
1997 -NZ$6.33 Million12.12%
1996 -NZ$5.65 Million106.25%
1995 -NZ$2.74 Million-11.11%
1994 -NZ$3.08 Million50%
1993 -NZ$2.06 Million20%
1992 -NZ$1.71 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.22 Billion 388.83%๐Ÿ‡บ๐Ÿ‡ธ USA